Morihide Ando
Nagoya University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Morihide Ando.
Clinical Respiratory Journal | 2017
Toru Oga; Hiroyuki Taniguchi; Hideo Kita; Tomomasa Tsuboi; Keisuke Tomii; Morihide Ando; Eiji Kojima; Hiromi Tomioka; Yoshio Taguchi; Yusuke Kaji; Ryoji Maekura; Toru Hiraga; Naoki Sakai; Tomoki Kimura; Michiaki Mishima; Kazuo Chin
Health status and mortality are important outcomes in patients with advanced pulmonary diseases receiving noninvasive ventilation (NIV). However, their relationship has not been thoroughly investigated.
Respiratory investigation | 2017
Toru Oga; Hiroyuki Taniguchi; Hideo Kita; Tomomasa Tsuboi; Keisuke Tomii; Morihide Ando; Eiji Kojima; Hiromi Tomioka; Yoshio Taguchi; Yusuke Kaji; Ryoji Maekura; Toru Hiraga; Naoki Sakai; Tomoki Kimura; Michiaki Mishima; Wolfram Windisch; Kazuo Chin
BACKGROUND The Severe Respiratory Insufficiency (SRI) Questionnaire was originally developed in German to assess health-related quality of life (HRQL) and was validated as a multidimensional instrument with high psychometric properties in chronic hypercapnic respiratory failure (CHRF) patients receiving noninvasive ventilation (NIV). We aimed to investigate the intercultural adaptation of the Japanese SRI Questionnaire and whether it is a reliable and valid HRQL questionnaire to administer to those patients. METHODS The SRI Questionnaire was adapted to Japanese using a translation and back-translation procedure, followed by equivalency assessment. It was validated in 56 stable outpatients receiving NIV for CHRF, primarily due to chronic obstructive pulmonary disease (COPD) and/or pulmonary tuberculosis sequelae. RESULTS Examination of the frequency distribution of the Japanese SRI Questionnaire showed that the subscales and summary were approximately normally distributed and well balanced. There were no significant differences in SRI scores between patients with COPD and pulmonary tuberculosis sequelae. Cronbach׳s α values representing internal consistency of seven SRI subscales ranged from 0.56 to 0.80; attendant symptoms and sleep had the lowest values. Cronbach׳s α value was 0.92 for the SRI summary. The SRI summary score was significantly related to all eight subscales of the Medical Outcomes Study 36-item short form, with correlation coefficients of 0.41-0.66. CONCLUSIONS The Japanese SRI Questionnaire was produced using a standardized procedure and an equivalency study. It has high psychometric properties with internal consistency and concurrent validity. The Japanese SRI Questionnaire can be used to assess HRQL in patients on NIV for CHRF.
Canadian Respiratory Journal | 2017
Toru Oga; Hiroyuki Taniguchi; Hideo Kita; Tomomasa Tsuboi; Keisuke Tomii; Morihide Ando; Eiji Kojima; Hiromi Tomioka; Yoshio Taguchi; Yusuke Kaji; Ryoji Maekura; Toru Hiraga; Naoki Sakai; Tomoki Kimura; Michiaki Mishima; Wolfram Windisch; Kazuo Chin
Background Two disease-specific questionnaires have been developed to assess health-related quality of life (HRQL) in patients with chronic respiratory failure: the Severe Respiratory Insufficiency (SRI) Questionnaire and the Maugeri Respiratory Failure (MRF) Questionnaire. We aimed to compare the characteristics of the SRI, MRF-26, and St. Georges Respiratory Questionnaire (SGRQ) for use in patients with home noninvasive ventilation (NIV). Methods Fifty-six outpatients receiving long-term NIV were recruited and underwent assessments of pulmonary function, arterial blood gas, HRQL, dyspnea, and psychological status. Results Correlations of the SRI and MRF-26 with the SGRQ were modest. While pulmonary function was weakly related to only some domains of the SRI and MRF-26, the modified Medical Research Council (mMRC) dyspnea scale and Hospital Anxiety and Depression Scale (HADS) were significantly related to all domains of the SRI and MRF-26. Multiple regression analyses showed that HADS depression and mMRC accounted for 34% and 27% of the variance in the SRI, 24% and 37% in the MRF-26, and 17% and 46% in the SGRQ, respectively. Conclusions The SRI and MRF-26 were reliable questionnaires for patients receiving long-term NIV. Dyspnea and psychological status were their main common determinants. The SRI covers more psychological health impairments than the MRF. This trial is registered with ClinicalTrials.gov Identifier: NCT00905476.
Clinical and Experimental Pharmacology and Physiology | 1993
Tsunekazu Hirano; Morihide Ando; Kenji Suzuki; Hidehiko Furui; Kenichi Miyamoto; Kenzo Takagi
1. We investigated the effects of new xanthine derivatives, 1‐methyl‐3‐propyl xanthine (MPX) and 1,3‐dipropyl xanthine (DPX), and several other xanthine derivatives on N‐formyl‐methionyl‐leucyl‐phenylalanine‐induced superoxide and lysozyme release from human polymorphonuclear leucocytes (PMN).
Biochemical and Biophysical Research Communications | 1992
Morihide Ando; Hidehiko Furui; Kenji Suzuki; Fumio Taki; Kenzo Takagi
The Japanese journal of thoracic diseases | 1992
Yasuhiro Kondoh; Fumio Taki; Morihide Ando; Nobuya Ikuta; Kouhei Matsumoto; Hitoshi Tanaka; Ryujiro Suzuki; Kenichi Yamaki; Kinzou Takagi; Yoshinori Kawabata; Kenji Suzuki
The Japanese journal of thoracic diseases | 1993
Nobuyasu Araki; Kohei Matsumoto; Nobuya Ikuta; Morihide Ando; Fumio Taki; Ryujiro Suzuki; Kenzo Takagi
European Respiratory Journal | 2015
Akira Shiraki; Morihide Ando; Takashi Abe; Harunori Nakashima; Michiko Hibi; Hirohisa Kano; Show Hori
European Respiratory Journal | 2015
Toru Oga; Hiroyuki Taniguchi; Hideo Kita; Tomomasa Tsuboi; Keisuke Tomii; Morihide Ando; Eiji Kojima; Hiromi Tomioka; Yoshio Taguchi; Yusuke Kaji; Ryoji Maekura; Toru Hiraga; Naoki Sakai; Tomoki Kimura; Michiaki Mishima; Kazuo Chin
European Respiratory Journal | 2015
Hirohisa Kano; Akira Shiraki; Joe Shindoh; Morihide Ando; Takashi Abe; Harunori Nakashima; Michiko Hibi; Sho Hori